Style | Citing Format |
---|---|
MLA | Tofighi Z, et al.. "Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology." Jundishapur Journal of Natural Pharmaceutical Products, vol. 20, no. 2, 2025, pp. -. |
APA | Tofighi Z, Khoshayand M, Mofasseri M, Hamedani MP, Nasrabadi MT, Abhagi AM, Hadjiakhoondi A, Goodarzi S (2025). Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology. Jundishapur Journal of Natural Pharmaceutical Products, 20(2), -. |
Chicago | Tofighi Z, Khoshayand M, Mofasseri M, Hamedani MP, Nasrabadi MT, Abhagi AM, Hadjiakhoondi A, Goodarzi S. "Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology." Jundishapur Journal of Natural Pharmaceutical Products 20, no. 2 (2025): -. |
Harvard | Tofighi Z et al. (2025) 'Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology', Jundishapur Journal of Natural Pharmaceutical Products, 20(2), pp. -. |
Vancouver | Tofighi Z, Khoshayand M, Mofasseri M, Hamedani MP, Nasrabadi MT, Abhagi AM, et al.. Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology. Jundishapur Journal of Natural Pharmaceutical Products. 2025;20(2):-. |
BibTex | @article{ author = {Tofighi Z and Khoshayand M and Mofasseri M and Hamedani MP and Nasrabadi MT and Abhagi AM and Hadjiakhoondi A and Goodarzi S}, title = {Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology}, journal = {Jundishapur Journal of Natural Pharmaceutical Products}, volume = {20}, number = {2}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Tofighi Z AU - Khoshayand M AU - Mofasseri M AU - Hamedani MP AU - Nasrabadi MT AU - Abhagi AM AU - Hadjiakhoondi A AU - Goodarzi S TI - Optimization of Mangiferin From Mango (Mangifera Indica L.) Leaves Using Response Surface Methodology JO - Jundishapur Journal of Natural Pharmaceutical Products VL - 20 IS - 2 SP - EP - PY - 2025 ER - |